Internationale publicatielijst
2021
Hyun I, Bredenoord AL, Briscoe J, Klipstein S, Tan T. Human embryo research: beyond the primitive streak. Science, in press
Van Dijke I, van Wely M, Berkman BE, Bredenoord AL, Henneman L, Vliegenthart R, Repping S, Hendriks S (2021) Should germline genome editing be allowed? The effect of treatment characteristics on public acceptability. Human Reproduction 36(2):465–478
Lensink MA, Boers SN, Gulmans V, Jongsma KR, Bredenoord AL. Mini-gut feelings: Perspectives of people with CF on the ethics and governance of organoid biobanking. Personalised Medicine, in press
Lensink M, Jongsma K, Boers S, van Delden JJM, Bredenoord AL. Responsible research with human tissues: the need for reciprocity towards both collectives and individuals. American Journal of Bioethics, in press
Kool EM, van der Graaf R, Bos AME, Fauser BCJM, Bredenoord AL. Fair allocation of cryopreserved donor oocytes – towards an accountable process. Human Reproduction, in press
Bijlsma RM, Wouters RHP, Wessels H, Sleijfer S, Beerepoot LV, ten Bokkel Huinink D, van Cruijsen H, Heijns J, Lolkema MP, Steeghs N, van Voorthuizen T, Vulink AJE, Witteveen PO, Ausems MGEM, Bredenoord AL, May AM, Voest EE. Preferences to receive unsolicited findings of germline genome sequencing in a large population of cancer patients. ESMO Open, in press
2020
Schneemann SA, Boers SN, van Delden JJM, Nieuwenhuis EES, Fuchs SA, Bredenoord AL (2020) Ethics of organoid transplantation: first in children? Science Translational Medicine 12, Issue 552, eaau8471
Jongsma KR & Bredenoord AL (2020) Ethics Parallel Research: an approach for (early) ethical guidance of biomedical innovation. BMC Medical Ethics 21(1):81
Haselager DRE, Boers SN, Jongsma KR, Vinkers CH, Broekman MLD, Bredenoord AL (2020) Breeding brains? Patients’ and laymen’s perspectives on cerebral organoids. Regenerative Medicine 15(12):2351-2360
Sugarman J & Bredenoord AL (2020) Real-Time Ethics Engagement in Biomedical Research. EMBO Reports 21(2):e49919
Lensink MA, Boers SN, Jongsma KR, Carter SE, van der Ent CK, Bredenoord AL (2020) Organoids for personalized treatment of Cystic Fibrosis: Professional perspectives on the ethics and governance of organoid biobanking. Journal of Cystic Fibrosis S1569-1993(20)30921-8
Huele EH, Kool EM, Bos AME, Fauser BCJM, Bredenoord AL (2020) The ethics of embryo donation: what are the moral similarities and differences of surplus embryo and double gamete donation? Human Reproduction 35(10):2171-2178
Lensink MA, Jongsma KR, Boers SN, Noordhoek JJ, Beekman JM, Bredenoord AL (2020) Responsible use of organoids in precision medicine: the need for active patient participation. Development 147:1-5
Reincke CM, Bredenoord AL, van Mil MHW (2020) From deficit to dialogue in science communication the dialogue communication model requires additional roles from scientists. EMBO Reports 21(9):e51278
Jongsma KR, van den Heuvel JFM, Rake JWT, Bredenoord AL, Bekker MN (2020) User experiences with and recommendations for mobile health technology for hypertensive disorders of pregnancy: mixed methods study. Journal of Medical Internet Research 8(8):e17271
Torres-Padilla ME, Bredenoord AL, Jongsma KR, Lunkes A, Marelli L, Pinheiro I, Testa G (2020) Thinking ‘ethical’ when designing an international, cross-disciplinary biomedical research consortium. EMBO Reports 39(19):e105725
Schuitenmaker JM, Oude Nijhuis RAB, Bredenoord AL, Fockens P, Bredenoord AJ (2020) Investigator initiated research in times of COVID-19: let’s go digital! Neurogastroenterology and Motility 32(11):e14011
N Rajewsky, G Almouzni, SA Gorski, S Aerts, I Amit, MG Bertero, C Bock, AL Bredenoord, G Cavalli, S Chiocca, H Clevers, B De Strooper, A Eggert, J Ellenberg, XM Fernández, M Figlerowicz, SM Gasser, N Hubner, J Kjems, JA Knoblich, G Krabbe, P Lichter, S Linnarsson, JC Marine, J Marioni, MA Marti-Renom, MG Netea, D Nickel, M Nollmann, HR Novak, H Parkinson, S Piccolo, I Pinheiro, A Pombo, C Popp, W Reik, S Roman-Roman, P Rosenstiel, JL Schultze, O Stegle, A Tanay, G Testa, D Thanos, FJ Theis, ME Torres-Padilla, A Valencia, C Vallot, A van Oudenaarden, M Vidal, T Voet, LifeTime Community (2020) LifeTime and improving European Healthcare through cell-based interceptive medicine. Nature 587(7834):377-386
Bijlsma RM, Wouters RHP, Wessels H, Sleijfer S, Beerepoot LV, ten Bokkel Huinink D, van Cruijsen H, Heijns J, Lolkema MP, Steeghs N, van Voorthuizen T, Vulink AJE, Witteveen PO, Ausems MGEM, Bredenoord AL, May AM, Voest EE. Preferences to receive unsolicited findings of germline genome sequencing in a large population of cancer patients. ESMO Open, in press
Pereira Daoud AM, Popovic M, Dondorp WJ, Trani Bustos M, Bredenoord AL, Chuva de Sousa Lopes SM, Van Den Brink SC, Roelen BAJ, De Wert GMWR, Heindryckx B (2020) Modeling Human Embryogenesis: Scientific Progress Sparks Ethical and Policy Debate. Human Reproduction Update 26(6):779-798
Wouters R, van der Graaf R, Voest EE, Bredenoord AL (2020) Learning Healthcare Systems: highly needed but challenging. Learning Health Systems 4(3):e10211
Sugarman J and Bredenoord AL. Reflections on organoid ethics: Jeremy Sugarman and Annelien Bredenoord. Cell Stem Cell, in press
De Graeff N, Dijkman L, Jongsma K, Bredenoord AL. Fair governance of biotechnology: Patents, private governance and procedural justice. American Journal of Bioethics, in press
2019
Giesbertz N, Van Harten W, Bredenoord AL (2019) A duty to recontact: context matters. Nature Reviews Genetics 20(7):371-372
Sand M, Bredenoord AL, Jongsma KR. After the fact – the case of CRISPR babies (2019) European Journal of Human Genetics 27(11):1621-1624
Luykx JJ, van der Spek R, van Veen S, Lo-A-Foe W, Giesbertz NAA, Bredenoord AL, Palmboom GG (2019) Unconsented DNA testing in psychiatry: an (almost) no go? Lancet Psychiatry 6(8):641-642
Boers SN, Van Delden JJM, Bredenoord AL (2019) Organoids as hybrids: in favour of re-entanglement. Journal of Medical Ethics 45(2):131-139
de Graeff N, Jongsma KR, Johnston J, Hartley S, Bredenoord AL (2019) The ethics of genome editing technologies in non-human animals: a systematic review of reasons reported in the academic literature. Philosophical Transactions of the Royal Society B: Biological Sciences 374(1772):20180106
Kool EM, van der Graaf R, Bos AME, Fauser BCJM, Bredenoord AL (2019) What constitutes a reasonable compensation for oocyte donation: an analogy with living organ donation and medical research participation. Journal of Medical Ethics 45(11):736-741
Kool EM, van der Graaf R, Bos AME, Pieters JJPM, Custers IM, Fauser BCJM, Bredenoord AL (2019) Stakeholders views on the ethical aspects of oocyte banking for third-party assisted reproduction: a qualitative interview study with donors, recipients and professionals. Human Reproduction 34(5):842-850
de Windt TS, Niemansburg SL, Vonk LA, van Delden H, Roes KCB, Dhert WJA, Saris DBF, Bredenoord AL (2019) Ethics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials. Osteoarthritis and Cartilage 27(1):34-40.
Lensink M, Boers SN, Jongsma KR, Bredenoord AL (2019) Understanding (in) consent for governance. American Journal of Bioethics 19(5):43-45
van Wijk MP, Wouters RHP, Bredenoord AL, Kon M, Breugem CC (2019) If it ain’t broke don’t fix it. Ethics of splinting deformed newborn ears. Journal of Plastic, Reconstructive and Aesthetic surgery 72(8):1396-1402
Bezemer T, de Groot MCH, Blasse E, ten Berg MJ, Kappen TH, Bredenoord AL, van Solinge WW, Hoefer IE, Haitjema S (2019) A human(e) factor in clinical decision support systems. The journal of medical internet research 21(3):e11732
Maher N, Senders JT, Hulsbergen AFC, Lamba N, Parker M, Onnela JP, Smith TR, Bredenoord AL, Broekman MLD (2019) Passive data collection and use in health care: a systematic review of ethical issues. International Journal of Medical Informatics 129:242-247
2018
Boers SN and Bredenoord AL (2018) Consent for governance in the ethical use of organoids. Nature Cell Biology 20(6):642-645
Rivron N, Pera M, Rossant J, Martinez Arias A, Zernicka-Goetz M, Fu J, van den Brink S, Bredenoord A, Dondorp W, de Wert G, Hyun I, Munsie M, Isasi R (2018) Debate ethics of embryo models from stem cells. Nature 564(7735):183-185
Boers SN, Van Delden JJM, Bredenoord AL (2018) Organoids as Hybrids: ethical implications for the exchange of human tissues. Journal of Medical Ethics 45(2):131-139
Boers SN, de Winter-de Groot KM, Gulmans V, Noordhoek J, van der Ent CK, van Delden JJM, Bredenoord AL (2018) Mini organs in a dish: perspectives of adult Cystic Fibrosis (CF) patients and parents of young CF patients on organoid technology. Journal of Cystic Fibrosis 17(3):407-415
de Windt TS, Niemansburg SL, Vonk LA, van Delden JM, Roes KCB, Dhert WJA, Saris DBF, Bredenoord AL (2019) Ethics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials. Osteoarthritis and Cartilage 27(1):34-40
van Dijke I, Bosch L, Bredenoord AL, Cornel M, Repping S, Hendriks S (2018) The ethics of clinical applications of germline genome modification: a systematic review of reasons. Human Reproduction 33(9):1777-1796
Bijlsma RM, Wouters RHP, Wessels H, May AM, Ausems MGEM, Voest EE, Bredenoord AL (2018) Managing unsolicited findings in the genomics area: a qualitative interview study with cancer patients. Psycho-Oncology 27(4):1327-1333
Wouters RHP, Bijlsma RM, Frederix GWJ, Ausems MGEM, van Delden JJM, Voest EE, Bredenoord AL (2018) Is it our duty to hunt for pathogenic mutations? Trends in Molecular Medicine 1:3-6
Kool E, Bos AME, Graaf van der R, Fauser B, Bredenoord AL. Ethics of oocyte banking for third-party assisted reproduction. Human Reproduction Update, in press
Boeckhout M, Zielhuis GA, Bredenoord AL. The FAIR Guiding Principles for Data Stewardship: fair enough? European Journal of Human Genetics, in press
Mostert M, Bredenoord AL, Van Der Sloot B, Van Delden JJM (2018) From privacy to data protection in the EU: implications for Big Data health research. European Journal of Health Law 25:43-55
Bijlsma RM, Wessels H, May AM, Ausems MGEM, Voest EE, Bredenoord AL (2018) Cancer patients’ intentions towards receiving unsolicited genetic information obtained by Next Generation Sequencing. Familial Cancer 17(2):309-316
Jongsma KR and Bredenoord AL (2018) Geometry of trust: why we need to distinguish between horizontal and vertical trust. American Journal of Bioethics 18(4):48-50
Jongsma K, Bredenoord AL, Lucivero F (2018) Digital medicine: an opportunity to revisit the role of bioethicists. American Journal of Bioethics 18(9):69-70
Yarborough M, Bredenoord AL, Joyce N, Kimmelman J, Ogbogu U, Sena ES, Strech D, D’Abramo F, Dirnagl U. Ethical ties between pre-clinical researchers in translational neuroscience and patients in clinical trials. Plos Biology, in press
Mostert M, Koomen BM, Van Delden JJM, Bredenoord AL (2018) Privacy in Big Data Psychiatric and Behavioural Research: a Multiple-Case Study. International Journal of Law and Psychiatry 60:40-44
Appleby JB and Bredenoord AL. Should the 14 day rule for embryo research become the 28 day rule? EMBO Reports, in press
Hendriks S, Giesbertz NAA, Bredenoord AL, Repping S. The Dutch general public’s reasons in favour of and against genome modification. Human Reproduction Open, in press
Vos S, van Diest PJ, Ausems MGEM, van Dijk MR, de Leng WWJ, Bredenoord AL (2018) Ethical considerations for modern molecular pathology. Journal of Pathology 246(4):405-414
Boeckhout M, Scheltens P, Manders P, Smit C, Bredenoord AL, Zielhuis GA. Patients To Learn From: On the Need for Systematic Integration of Research and Care in Academic Health Care. Journal of Clinical and Translational Research, in press
2017
Bredenoord AL, Clevers J, Knoblich J (2017) Human tissues in a dish: the research and ethical implications of organoid technology. Science 355(6322)
Bredenoord AL and Appleby JB (2017) Mitochondrial replacement techniques: remaining ethical challenges. Cell Stem Cell 21(3):301-304
Bredenoord AL and Hyun I (2017) Ethics of stem-cell derived gametes made in a dish: fertility for everyone? EMBO Molecular Medicine 4:396-398
Wouters R, Cornelis C, Newson AJ, Bunnik EM, Bredenoord AL (2017) Scanning the body, sequencing the genome: dealing with unsolicited findings. Bioethics 31(9):648-656
Cote DJ, Bredenoord AL, Smith TR, Ammirati M, Brennum J, Mendez I, Ammar AS, Balak N, Bolles G, Esene IN, Mathiesen T, Broekman ML (2017) Ethical clinical translation of stem cell interventions for neurological disease. Neurology 88(3):322-328
Bredenoord AL & Boeckhout M (2017) Ancillary care obligations for social media platforms. American Journal of Bioethics 3:29-31
Vos S, Van Delden JJM, Van Diest PJ, Bredenoord AL (2017) Moral duties of genomics researchers: why personalized medicine requires a collective approach. Trends in Genetics 33(2):118-128
Habets MGJL, Van Delden JJM, Bredenoord AL (2017) The unique status of first-in-human studies: strengthening the social value requirement. Drug Discovery Today 22(2):471-475
Muskens IS, Diederen SJH, Senders JT, Zamanipoor Najafabadi AH, van Furth WR, May AM, Smith TR, Bredenoord AL, Broekman MLD (2017) Innovation in neurosurgery: less than IDEAL? A systematic review. Acta Neurochirurgica 159(10):1957-1966
Bakker MR, Maas J, Bekker MH, Bredenoord AL, Fauser BC, Bos AM (2017) Autonomy and self-esteem of women who donate to an oocyte cryopreservation bank in The Netherlands. Reprod Biomed Online 35(2):225-231
2016
Habets MGJL, Van Delden JJM, Niemansburg SL, Atkins HL, Bredenoord AL (2016) One-size-fits-all? Ethical considerations for examining efficacy in first-in-human pluripotent stem cell studies. Molecular Therapy 24(12):2039-2042
Giesbertz NAA, Melham K, Kaye J, Van Delden JJM, Bredenoord AL (2016) Personalized Assent for Pediatric Biobanks. BMC Med Ethics 17(1):59
Wouters R, Bijlsma RM, Ausems MGEM, Voest EE, Van Delden JJM, Bredenoord AL (2016) Am I my family’s keeper? Disclosure dilemma’s in next generation DNA sequencing. Human Mutation 37(12):1257-1262
Otto IA, Breugem CC, Malda J, Bredenoord AL (2016) Ethical considerations in the translation of regenerative biofabrication technologies into clinic and society. Biofabrication 8(4):042001
Cornelis C, Tibben A, Dondorp W, van Haelst M, Bredenoord AL, Knoers N, Duwell M, Bolt I, van Summeren M (2016) Whole exome sequencing in pediatrics: Parents’ considerations toward return of unsolicited findings for their child. European Journal of Human Genetics 24(12):1681-1687
Broekman ML, Carriere M, Bredenoord AL (2016) Surgical innovation: the ethical agenda. Medicine 95(25):e3790
Boers SL, Van Delden JJM, Clevers H, Bredenoord AL (2016) Organoid biobanking: identifying the ethics. EMBO reports pii: e201642613
Broekman ML, Carriere M, Bredenoord AL (2016) Surgical innovation: the ethical agenda. Medicine 95(25):e3790
Daley GQ, Hyun I, Apperley J, Barker R, Benvenisty N, Bredenoord AL, Breuer C, Caulfield T, Cedars M, Frey-Vasconcells J, Heslop H, Jin Y, Lee RT, McCabe C, Munsie M, Murry C, Piantadosi S, Rao M, Sipp DA, Studer L, Sugarman J, Takahashi M, Zimmerman M, Kimmelman J (2016) Setting global standards for stem cell research and clinical translation: the 2016 ISSCR Guidelines. Stem Cell Reports 6(6):787-97
Bijlsma RM, Bredenoord AL, Gadella-Hooijdonk CG, Lolkema MPJ, Sleijfer S, Voest EE, Ausems MGEM, Steeghs N (2016) Unsolicited findings of Next Generation Sequencing for tumor analysis within a Dutch consortium: Clinical daily practice reconsidered. European Journal of Human Genetics 24(10):1496-500
Giesbertz NAA, Bredenoord AL, Van Delden JJM. When children become adults: should biobanks re-contact? PloS Medicine 13(2):e1001959
MGJL Habets, Van Delden JJM, Bredenoord AL (2016) Studying the lay of the land: views and experiences of professionals in the translational pluripotent stem cell field. Regenerative Medicine 11(1):63-71
Mostert M, Bredenoord AL, Biesaart M, Van Delden JJM (2016) Big Data in medical research and EU data protection law: challenges to the consent or anonymise approach. European Journal of Human Genetics 24(7):956-60
Veldwijk J, Lambooij MS, Kallenberg FGJ, van Kranen HJ, Bredenoord AL, Dekker E, Smit HA, de Wit GA (2016) Preferences for genetic screening for colectoral cancer within a population-based screening program: a discrete choice experiment. European Journal of Human Genetics 24(3):361-6
2015
Niemansburg SL, Habets MGJL, Van Delden JJM, Bredenoord AL (2015) Participant selection for preventive Regenerative Medicine trials: ethics of including individuals at risk. Journal of Medical Ethics 41(11):914-6
Bredenoord AL, Mostert M, Isasi R, Knoppers BM (2015) Data Sharing in Stem Cell Translational Science: Policy Statement by the International Stem Cell Forum Ethics Working Party. Regenerative Medicine 10(7):857-61
Boers SL, Van Delden JJM, Bredenoord AL (2015) Broad consent is consent for governance. American Journal of Bioethics 15(9):53-5
Giesbertz NAA, Bredenoord AL, Van Delden JJM (2015) Consent procedures in pediatric biobanks. European Journal of Human Genetics 23:1129-1134
Bredenoord AL, Bijlsma R, Van Delden JJM (2015) Next generation DNA sequencing: always allow an opt out. American Journal of Bioethics 15(7):28-30
Bredenoord AL and Hyun I (2015) The road to mitochondrial gene transfer: follow the middle lane. Molecular Therapy 23(6):975-6
Janssen S, Bredenoord AL, Dhert W, Oner C, Verlaan JJ (2015) Potential conflict of interest of editorial board members of five leading spine journals. PloS One 10(6):e0127362
Boers S, Van Delden JJM, Knoers N, Bredenoord AL (2015) Postmortem disclosure of genetic information to family members: active or passive disclosure? Trends Mol Med 21/3:148-153
Bosley KS, Botchan M, Bredenoord AL, Carroll D, Charo RA, Charpentier E, Cohen R, Corn J, Doudna J, Feng G, Greely HT, Isasi R, Ji W, Kim JS, Knoppers B, Lanphier E, Li J, Lovell-Badge R, Martin GS, Moreno J, Naldini L, Pera M, Perry AC, Venter JC, Zhang F, Zhou Q (2015) CRISPR germline engineering: the community speaks. Nature Biotechnology 33(5):478-486
Bredenoord AL. The Principles of Biomedical Ethics Revisited. In: Ramadan T, Audi J (eds) Principles of Islamic Biomedical Ethics. Bloomsbury Publishing, forthcoming
van Delden JJM and Bredenoord AL. Future challenges for bioethics: regenerative medicine. UNESCO. In: Global Bioethics: what for? 20th anniversary of UNESCO’s Bioethics Program. German Solinis (ed), Paris: UNESCO publishing 2015, pp 137-141
Niemansburg SL, Tempels TH, Dhert WJA, Van Delden JJM, Bredenoord AL (2015) Societal Impacts of Regenerative Medicine: reflection on the views of orthopedic professionals. Regenerative Medicine 10(1):17-24
Niemansburg SL, Van Delden JJM, Dhert WJA, Bredenoord AL (2015) Reconsidering the ethics of sham interventions in an era of emerging technologies. Surgery pii: S0039-6060(14)00786-7
Giesbertz NAA, Bredenoord AL, Van Delden JJM (2015) Consent procedures in pediatric biobanks. European Journal of Human Genetics 23:1129-1134
2014
Mooien WA, Bredenoord AL, Viergever RF, Peul WC (2014) Scientific evaluation of spinal implants; an ethical necessity. Spine 39:2115-2118
Habets MGJL, Van Delden JJM, Bredenoord AL (2014) The Social Value of Clinical Research. BMC Medical Ethics 15(1):66
Niemansburg SL, Teraa M, Hesam H, Van Delden JJM, Verhaar MC, Bredenoord AL (2014) Stem cell trials for vascular medicine: ethical rationale. Tissue Engineering part A, 20(19-20):2567-74
Peul WC, Bredenoord AL, Jacobs WCH (2014) Avoid surgery as first line treatment for non-specific low back pain. British Medical Journal 349:g4214
Bredenoord AL, De Vries MC, Van Delden JJM (2014) The right to an open future concerning genetic information. American Journal of Bioethics 14(3):21-3
Koudstaal S, Niemansburg SL, Dib N, Wallet J, Doevendans PA, Bredenoord AL, Chamuleau SAJ (2014) Placebo in autologous cell-based interventions: hard pill to swallow? Journal of the American College of Cardiology 63(25 Pt A):2877-9
Niemansburg SL, Habets MGJL, Van Delden JJM, Bredenoord AL (2014) Disclosure of risks and uncertainties are especially vital in light of Regenerative Medicine. American Journal of Bioethics 14(4):14-6
Isasi R, Knoppers BM, Andrews PW, Bredenoord AL, Colman A, Hin LE, Hull S, Kim OJ, Lomax G, Morris C, Sipp D, Stacey G, Wahlstrom J, Zeng F; for the International Stem Cell Forum Ethics Working Party (2014) Identifiability and Privacy in Pluripotent Stem Cell Research. Cell Stem Cell 14:427-430
Habets MGJL, Van Delden JJM, Bredenoord AL (2014) The inherent ethical challenge of first-in-human pluripotent stem cell trials. Regenerative Medicine 9(1):1-3
Giesbertz NAA, Bredenoord AL, Van Delden JJM (2014) Reply to Waligora. European Journal of Human Genetics 22:855
Giesbertz NAA, Bredenoord AL, Van Delden JJM (2014) Clarifying assent in pediatric research. European Journal of Human Genetics 22(2):266-9
Knoppers BM, Avard D, Sénécal K, Zawati MH along with the P3G International Paediatrics Platform members Bredenoord AL, Hall A, Hens K, Pinxten W, Wallace S, Parry D, Clayton EW (2014) Return of Whole-Genome Sequencing Results in Paediatric Research. European Journal of Human Genetics 22(1):3-5
Niemansburg SL, Van Delden JJM, Oner FC, Dhert WJA, Bredenoord AL (2014) Ethical implications of regenerative medicine in orthopedics: an empirical study with surgeons and scientists in the field. The Spine Journal 14(6):1029-1035
2013
Lolkema MP, Gadellaa – van Hooijdonk CG, Bredenoord AL, Voest EE (2013) Reply to Battistuzzi et al. Journal of Clinical Oncology 31(32):4165-6
Bredenoord AL, Giesbertz NAA, Van Delden JJM (2013) Consent for medical device registries. Public Health Ethics 6(2):226-229
Bredenoord AL, De Vries MC, Van Delden JJM (2013) Next Generation Sequencing: does the next generation still have a right to an open future? Nature Reviews Genetics 14:306 doi:10.1038/nrg3459
Giesbertz NAA, Bredenoord AL, Van Delden JJM (2013) A thick opt-out is often sufficient. American Journal of Bioethics 13(4):44-46
Lolkema MP, Gadellaa – van Hooijdonk CG, Bredenoord AL, Kapitein P, Roach N, Cuppen E, Knoers NV, Voest EE (2013) Ethical and counselling challenges surrounding the return of genetic results in oncology. Journal of Clinical Oncology 31(15):1842-8
Niemansburg SL, Van Delden JJM, Dhert WJA, Bredenoord AL (2013) Regenerative medicine interventions for orthopedic disorders: ethical issues in the translation into patients. Regenerative Medicine 8(1):65-73
2012
Giesbertz NAA, Bredenoord AL, Van Delden JJM (2012) Inclusion of Residual Tissue in Biobanks: Opt-in or Opt-out? PLoS Biology 10(8): e1001373
Bredenoord AL and Van Delden JJM (2012) Disclosing individual genetic research results to deceased participants’ relatives by means of a qualified disclosure policy. American Journal of Bioethics 12(10):10-12
Isasi R, Knoppers BM, Andrews PW, Bredenoord AL, Colman A, Hin LE, Hull S, Kim OJ, Lomax G, Morris C, Sipp D, Stacey G, Wahlstrom J, Zeng F; for the International Stem Cell Forum Ethics Working Party (2012) Disclosure and management of research findings in stem cell research and banking: policy statement. Regenerative Medicine 7(3):439-448
Van der Baan FH, Bernabe R, Bredenoord AL, Gregoor JG, Meynen G, van Thiel GJMW. Consent in psychiatric biobanks for pharmacogenetic research (2012) International Journal of Neuropsychopharmacology 21:1-6
Bredenoord AL, Lock MTW, Broekmans F (2012) Ethics of intergenerational (father-to-son) sperm donation. Human Reproduction 27(5):1286-1291
Bredenoord AL and Van Delden JJM (2012) Research ethics in genomics research: feedback of individual genetic data to research participants. In: Human Medical Research: Ethical, Economic and Socio-Cultural aspects. Vollmann J, Schildmann J and Sandow V (eds) Basel: Springer pp 127-136
2011
Bredenoord AL, Onland-Moret NC, Van Delden JJM (2011) Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy. Human Mutation 32:1–7
Bredenoord AL, Kroes HY, Cuppen E, Parker M, Van Delden JJM (2011) Disclosure of individual genetic data to research participants: the debate reconsidered. Trends in Genetics 27(2):41-47
Bredenoord AL, Dondorp WJ, Pennings G, De Wert G (2011) Nuclear transfer to prevent mitochondrial DNA disorders: revisiting the debate on reproductive cloning. Reproductive Biomedicine Online 22:200-207
Bredenoord AL, Dondorp WJ, Pennings G, De Wert G (2011) Ethics of modifying the mitochondrial genome. Journal of Medical Ethics 37:97-100
2010
Bredenoord AL and Braude P (2010) Ethics of mitochondrial gene replacement: from bench to bedside. British Medical Journal 341:c6021
Poulton J and Bredenoord AL (2010) 174th ENMC International Workshop: Applying Pre-implantation Genetic Diagnosis to mtDNA Diseases: Implications of Scientific Advances. 19-21 March 2010, Naarden, The Netherlands. Neuromuscular Disorders 20:559-563
Van der Weijden CP, Bredenoord AL, Van Delden JJM (2010) The duty to treat in the context of an influenza pandemic. Vaccine 28:5260-5264
Bredenoord AL, Dondorp WJ, Pennings G, De Wert G (2010) Avoiding transgenerational health risks of mitochondrial DNA disorders: a morally acceptable reason for sex selection? Human Reproduction 25:1354-1360
Bredenoord AL, Van der Graaf R, Van Delden JJM (2010) Towards a “post-posthuman dignity area” in evaluating emerging enhancement technologies. American Journal of Bioethics 10(7):55-57
Bredenoord AL, Krumeich A, De Vries MC, Dondorp WJ, De Wert G (2010) Reproductive decision-making in the context of mitochondrial DNA disorders: experiences of professionals. Clinical Genetics 77(1):10-17
2009
Bredenoord AL, Dondorp WJ, Pennings G, De Die-Smulders CEM, Smeets HJ, De Wert G (2009) Preimplantation genetic diagnosis for mitochondrial DNA disorders. Ethical guidance for clinical practice. European Journal of Human Genetics 17:1550-1559
2008
Bredenoord AL, Pennings G, De Wert G (2008) Ooplasmic transfer and nuclear transfer to prevent mitochondrial DNA disorders: conceptual and normative issues. Human Reproduction Update 14(6):669-678
Bredenoord AL, Dondorp WJ, Pennings G, De Die-Smulders CEM, De Wert G (2008) PGD to reduce reproductive risk: the case of mitochondrial DNA disorders. Human Reproduction 23(11):2392-2401
Bredenoord AL, Pennings G, Smeets HJ, de Wert G (2008) Dealing with uncertainties. Ethics of prenatal diagnosis and preimplantation genetic diagnosis for mitochondrial disorders. Human Reproduction Update 14(1):83-94
Nederlandstalige publicatielijst
Annelien Bredenoord, Morele Vooroordelen. In: M. Geels & T. van Opijnen (red), Waar verzet jij je tegen? Amsterdam: Maven Publishing 2017
Annelien Bredenoord, Medische Ethiek. In: Th. de Graaf (red), Redelijk Radicaal: 50 jaar D66. Amsterdam: Balans, 2016
Annelien Bredenoord, ‘Samen beslissen in de zorg: een sociaal-liberale invulling’. Idee nr 1: Gezondheid:mij ’n zorg! 2016:15-18
Martine de Vries & Annelien Bredenoord (2014) Next Generation Sequencing: heeft de volgende generatie nog recht op een open toekomst? Tijdschrift voor Kindergeneeskunde 82(1):45-48
Annelien Bredenoord, Reproductieve autonomie ontrafeld. Tijdschrift voor Gezondheidszorg en Ethiek 2013; 23(3):84
Annelien Bredenoord, Ethiek van het persoonlijk genoom. Huisarts&Wetenschap, Oktober 2012
Annelien Bredenoord, Zwanger worden van een kind met het Huntington-gen? In: de Ruijter et al (eds) Huisarts tussen individu en familie. Morele dilemma’s in de huisartspraktijk. Assen: Van Gorcum 2012, pp 25-28
Annelien Bredenoord, ‘Kies je kids’? Reproductieve autonomie. Idee (April 2011):21-27
Annelien Bredenoord, Boek review in Tijdschrift voor Gezondheidszorg & Ethiek (2004:3): van der Kwaak et al (eds), “Strategies of preventing female circumcision”, Doetinchem 2003
Annelien Bredenoord, ‘D66 en religie’. Idee (2002) 23:4